We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CRTX market cap is 73.13M. The company's latest EPS is USD -0.0069 and P/E is -7.61.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1,000 | 0 | 915k | 0 | 512k |
| Operating Income | -1.98M | -3.09M | -1.59M | -1.65M | -694k |
| Net Income | -2.33M | -2.67M | -1.21M | -3.01M | -9.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.27M | 32.4M | 31.24M | 28.74M | 4.79M |
| Total Liabilities | 1.13M | 1.05M | 1.13M | 921k | 662k |
| Total Equity | 27.14M | 31.35M | 30.11M | 27.82M | 4.12M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.9M | -2.2M | -1.83M | -3.36M | -2.77M |
| Investing | -500k | -5.18M | 6.04M | -186k | 34.93M |
| Financing | 1.5M | 9.89M | N/A | 345k | -31.45M |
| Market Cap | 73.13M |
| Price to Earnings Ratio | -7.61 |
| Price to Sales Ratio | 131.25 |
| Price to Cash Ratio | 16.94 |
| Price to Book Ratio | 17.73 |
| Dividend Yield | - |
| Shares Outstanding | 1.39B |
| Average Volume (1 week) | 21.51k |
| Average Volume (1 Month) | 53.29k |
| 52 Week Change | -78.13% |
| 52 Week High | 24.00 |
| 52 Week Low | 5.25 |
| Spread (Intraday) | 0.5 (9.09%) |
| Company Name | Crism Therapeutics Corporation |
| Address |
kingston chambers road town, tortola |
| Website | https://www.amurminerals.com |
| Industry | mineral royalty traders (6795) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
